Jump to content

Wikipedia:Articles for deletion/ActoGeniX

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Jtamad (talk | contribs) at 04:18, 21 April 2017. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

ActoGeniX (edit | talk | history | protect | delete | links | watch | logs | views) – (View log · Stats)
(Find sources: Google (books · news · scholar · free images · WP refs· FENS · JSTOR · TWL)

Promotional article for pharmaceutical company. Multiple use of trademarks. No approved products. Various medical claims are made based upon individual journalarticles, that do not meet MEDRS standards. DGG ( talk ) 08:55, 9 April 2017 (UTC)[reply]

Note: This debate has been included in the list of Companies-related deletion discussions. CAPTAIN RAJU (✉) 11:19, 9 April 2017 (UTC)[reply]
Note: This debate has been included in the list of Belgium-related deletion discussions. CAPTAIN RAJU (✉) 11:20, 9 April 2017 (UTC)[reply]
Note: This debate has been included in the list of Medicine-related deletion discussions. • Gene93k (talk) 02:39, 17 April 2017 (UTC)[reply]
  • Note
ActoBiotics (edit | talk | history | protect | delete | links | watch | logs | views)
(Find sources: Google (books · news · scholar · free images · WP refs· FENS · JSTOR · TWL)

- - I have bundled ActoBiotics with this. Created by same editor, equally as non-notable and promotional. Jytdog (talk) 03:03, 17 April 2017 (UTC)[reply]

Relisted to generate a more thorough discussion and clearer consensus.
Relisting comment: Note that on 17 April 2017 ActoBiotics was added to this nomination page and the AfD template was added atop that article.
Please add new comments below this notice. Thanks, North America1000 03:56, 17 April 2017 (UTC)[reply]
yes, that makes sense to me also. DGG ( talk ) 20:37, 19 April 2017 (UTC)[reply]
This proposed therapeutic agent is only in phase 1 trials in humans. Not worthy of an article. May not pan out. If it does, then later a mention in a more general article on oral bio-pharmaceuticals in general or the Lactococcus article might be appropriate. JuanTamad (talk) 04:18, 21 April 2017 (UTC)[reply]